dockets: FDA-2026-N-3273
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2026-N-3273 | FDA | Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments” | Nonrulemaking | 2026-04-15T13:05:22Z | 0b000064b9240b98 |
Links from other tables
- 1 row from docket_id in documents